ResearcherChiba UniversityActive in the last 2 years
Yoji Miyahara
Matched on ORCID iD 0000-0001-5636-2607; OpenAlex author ID A5014555341. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 27
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 4 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper
Papers 7
- [Multidisciplinary Therapy Mainly Including Surgery for Hemorrhage Due to Duodenal Invasion of Pancreatic Cancer-A Case Report]. Co-author PMID 41546309↗
- Prosaposin, tumor-secreted protein, promotes pancreatic cancer progression by decreasing tumor-infiltrating lymphocytes. Co-author DOI 10.1111/cas.15444↗
- Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. Co-author DOI 10.1007/s13402-021-00614-z↗
- PTHrP Drives Pancreatic Cancer Growth and Metastasis and Reveals a New Therapeutic Vulnerability. Co-author DOI 10.1158/2159-8290.cd-20-1098↗
- C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pan… Co-author DOI 10.1186/s13046-021-02019-0↗
- Fucosylated C4b-binding protein α-chain, a novel serum biomarker that predicts lymph node metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ol.2020.12388↗
- [A Case of R0 Resection of Locally Advanced Pancreatic Cancer Following Chemoradiation Therapy]. Co-author PMID 26805371↗
Closest collaborators
The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shigetsugu Takano · 6 shared papers, 2015–2022 · strength 0.67
- Paper Prosaposin, tumor-secreted protein, promotes pancreatic cancer progression by decreasing tumor-infiltrating lymphocytes. DOI 10.1111/cas.15444↗
- Paper C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocy… DOI 10.1186/s13046-021-02019-0↗
- Paper Fucosylated C4b-binding protein α-chain, a novel serum biomarker that predicts lymph node metastasis in pancreatic duct… DOI 10.3892/ol.2020.12388↗
- Masayuki Ohtsuka · 6 shared papers, 2015–2022 · strength 0.67
- Paper Prosaposin, tumor-secreted protein, promotes pancreatic cancer progression by decreasing tumor-infiltrating lymphocytes. DOI 10.1111/cas.15444↗
- Paper C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocy… DOI 10.1186/s13046-021-02019-0↗
- Paper Fucosylated C4b-binding protein α-chain, a novel serum biomarker that predicts lymph node metastasis in pancreatic duct… DOI 10.3892/ol.2020.12388↗
- Katsunori Furukawa · 5 shared papers, 2015–2022 · strength 0.57
- Paper Prosaposin, tumor-secreted protein, promotes pancreatic cancer progression by decreasing tumor-infiltrating lymphocytes. DOI 10.1111/cas.15444↗
- Paper C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocy… DOI 10.1186/s13046-021-02019-0↗
- Paper Fucosylated C4b-binding protein α-chain, a novel serum biomarker that predicts lymph node metastasis in pancreatic duct… DOI 10.3892/ol.2020.12388↗
- Kazuyuki Sogawa · 3 shared papers, 2021–2022 · strength 0.40
- Paper Prosaposin, tumor-secreted protein, promotes pancreatic cancer progression by decreasing tumor-infiltrating lymphocytes. DOI 10.1111/cas.15444↗
- Paper Fucosylated C4b-binding protein α-chain, a novel serum biomarker that predicts lymph node metastasis in pancreatic duct… DOI 10.3892/ol.2020.12388↗
- Paper Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. DOI 10.1007/s13402-021-00614-z↗
- Kosuke Sasaki · 3 shared papers, 2021 · strength 0.37
- Paper C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocy… DOI 10.1186/s13046-021-02019-0↗
- Paper Fucosylated C4b-binding protein α-chain, a novel serum biomarker that predicts lymph node metastasis in pancreatic duct… DOI 10.3892/ol.2020.12388↗
- Paper Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. DOI 10.1007/s13402-021-00614-z↗
- Satoshi Tomizawa · 2 shared papers, 2021–2022 · strength 0.30
- Paper Prosaposin, tumor-secreted protein, promotes pancreatic cancer progression by decreasing tumor-infiltrating lymphocytes. DOI 10.1111/cas.15444↗
- Paper C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocy… DOI 10.1186/s13046-021-02019-0↗
- Hisashi Kametaka · 1 shared paper, 2025 · strength 0.25
- Kazuhiro Seike · 1 shared paper, 2025 · strength 0.25
- Hironobu Makino · 1 shared paper, 2025 · strength 0.25
- Fumio Nomura · 2 shared papers, 2021 · strength 0.23
- Paper Fucosylated C4b-binding protein α-chain, a novel serum biomarker that predicts lymph node metastasis in pancreatic duct… DOI 10.3892/ol.2020.12388↗
- Paper Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. DOI 10.1007/s13402-021-00614-z↗
- Shingo Kagawa · 2 shared papers, 2015–2021 · strength 0.15
- Masaru Miyazaki · 2 shared papers, 2015–2021 · strength 0.15
- Hideyuki Yoshitomi · 2 shared papers, 2015–2021 · strength 0.15
- Reiri Shimazaki · 1 shared paper, 2021 · strength 0.11
- Mamoru Satoh · 1 shared paper, 2021 · strength 0.11
- Robert J. Norgard · 1 shared paper, 2021 · strength 0.10
- Jinyang Li · 1 shared paper, 2021 · strength 0.10
- Benoît Marchand · 1 shared paper, 2021 · strength 0.10
- Jun Zhao · 1 shared paper, 2021 · strength 0.10
- Kensuke Suzuki · 1 shared paper, 2021 · strength 0.10
- Ben Z. Stanger · 1 shared paper, 2021 · strength 0.10
- Anil K. Rustgi · 1 shared paper, 2021 · strength 0.10
- Anirban Maitra · 1 shared paper, 2021 · strength 0.10
- Jason Robert Pitarresi · 1 shared paper, 2021 · strength 0.10
- Basil S. Bakir · 1 shared paper, 2021 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.